Food producing animals can be reservoirs of Campylobacter, a leading bacterial cause of human foodborne illness. Campylobacter spp. utilize amino acids as major carbon and energy substrates, a process that can be inhibited by thymol and diphenyliodonium chloride (DIC). To determine the effect of these potential additives on feed intake, live weight gain, and gut Campylobacter levels, growing pigs were fed standard grower diets supplemented with or without 0.0067 or 0.0201% thymol or 0.00014 or 0.00042% DIC in a replicated study design. Diets were offered twice daily for 7 days, during which time daily feed intake (mean ¡ SEM, 2.39 ¡ 0.06 kg day 21 ) and daily gain (0.62 ¡ 0.04 kg day 21 ) were unaffected (P . 0.05) by treatment. Pigs treated with DIC but not thymol tended to have lower rectal Campylobacter levels (P~0.07) (5.2 versus 4.2 and 4.4 log CFU g 21 rectal contents for controls and 0.00014% DIC and 0.00042% DIC, respectively; SEM~0.26). However, DIC or thymol treatments did not affect (P . 0.05) ileal or cecal Campylobacter (1.6 ¡ 0.17 and 4.5 ¡ 0.26 log CFU g 21 , respectively), cecal total culturable anaerobes (9.8 ¡ 0.10 log CFU g 21 ), or accumulations of major fermentation end products within collected gut contents. These results suggest that thymol and DIC were appreciably absorbed, degraded, or otherwise made unavailable in the proximal alimentary tract and that encapsulation technologies will likely be needed to deliver effective concentrations of these compounds to the lower gut to achieve in vivo reductions of Campylobacter.
Campylobacter infection is a leading bacterial cause of human foodborne disease, responsible for 13 reported cases per every 100,000 persons per year in the U.S. population (4) at an annual cost of more than $1.2 billion (7). Whereas most human Campylobacter infections are caused by Campylobacter jejuni, an estimated 26,000 infections are caused annually by Campylobacter coli, which is the predominant Campylobacter species found in swine (10, 20) . Both Campylobacter species are recognized as important reservoirs of antimicrobial resistance genes that can be transmitted to other pathogenic or commensal bacteria (21, 22) . Consequently, an important step toward lowering numbers of foodborne illnesses would be to reduce the colonization and carriage of Campylobacter in food animals before they arrive for processing.
Campylobacter lacks 6-phosphofructokinase (26) and thus is limited in its ability to obtain carbon or energy from sugars or carbohydrates. Campylobacter may conserve energy via respiration using a variety of electron acceptors (13) , but because concentrations of anaerobic electron acceptors are typically low in gut environments Campylobacter growth also may be limited. Recent evidence has revealed strain-specific uptake and utilization of L-fucose by a putative fucose-permease expressed by C. jejuni; however, this ability is not necessarily required to promote colonization of the chick ceca (14) . Conversely, most Campylobacter strains utilize amino acids such as alanine, aspartate, glutamate, glutamine, methionine, and serine as carbon and energy substrates (16, 27) , and the ability to metabolize these amino acids enables colonization of the gut of animals. For instance, a C. jejuni mutant lacking L-serine dehydratase activity and thus deficient in L-serine catabolism was unable to colonize the avian gut (25) . The ability of a virulent C. jejuni strain to catabolize aspartate and glutamate or glutamate precursors reportedly promoted this strain's ability to colonize the host (8, 9). Results of a previous study suggested that inhibition of amino acid catabolism using the purported deaminase inhibitors diphenyliodonium chloride (DIC) and thymol (2) may explain the observed reductions (.5 log) in survivability of C. jejuni and C. coli during incubation with swine fecal microbes in vitro (1) . Although these study results confirmed that DIC inhibited enzymatic catabolism of amino acids, as evidenced by significant reductions in specific ammonia-producing activity by crude C. jejuni and C. coli enzyme preparations, the case was less clear with thymol. This inhibitor reduced the specific ammoniaproducing activity by enzyme preparations of C. coli but not of C. jejuni (1) . Consequently, we could not clearly determine whether the bactericidal effect of thymol against Campylobacter was due to an inhibition of deaminase, as suggested by Broderick and Balthrop (2), or to the disruption of the bacterial cell wall as more generally thought by others (3, 17) . Regardless of the mode of action, results from our earlier in vitro studies clearly indicated that DIC and thymol are bactericidal against C. coli and C. jejuni and thus may be effective for reducing the carriage of important foodborne pathogens in animals. However, no one has determined whether pigs will find these inhibitors palatable or whether concentrations that reduce Campylobacter in vitro will likewise be effective in vivo. The primary objective of the present study was to determine the effect of thymol or DIC diet supplements on feed intake, live weight gain, and gut Campylobacter levels in a weaned pig model.
MATERIALS AND METHODS
In two separate trials, weaned pigs approximately 6 weeks of age were purchased from the Texas A&M University Animal Science Department and transported to the Southern Plains Agricultural Research Center's swine grow-out facility. The experimental trials were conducted in accordance with procedures approved by the Center's Animal Care and Use Committee. The pigs were randomly allocated to individual pens (two pigs per pen) and acclimated to a standard commercial grower diet (Producers Cooperative Association, Bryan, TX) for 3 weeks, after which pigs were fed diets supplemented with 0|, 1|, or 3| DIC or thymol, each purchased from Sigma-Aldrich (St. Louis, MO), where 1| is equivalent to 0.00014% DIC and 0.0067% thymol (each on a wt/ wt basis).
Treatments were administered by spraying each meal with 3 ml of concentrated stock solutions of DIC (2.13 or 6.39 mM prepared in water) or thymol (212.92 or 638.76 mM prepared in ethanol). Meals were offered at approximately 07:30 and 16:30 each day; consequently, each pen was considered an experimental unit (n~4 per treatment in each trial). Amounts of feed offered and refused were measured daily during a 7-day period for the first replicate, but because of scheduling conflicts these measurements were taken on only days 3, 5, 6, and 7 in the second replicate. Samples of feed offered and refused were collected, homogenized, and dried at 100uC until a constant weight was achieved, and the resultant dry matter percentages were used to adjust intakes to a dry matter basis.
On day 8 after initiation of treatment, all pigs were euthanized via intravenous sodium pentobarbital injection and necropsied for collection of ileal, cecal, and rectal contents. Contents were serially diluted into sodium phosphate-buffered saline (pH 6 (12) . Colonies were counted after 48 h of microaerobic incubation (N 2 :CO 2 :O 2~8 5:10:5) at 42uC. Cecal contents also were diluted into anaerobic buffer that was prepared under 100% N 2 and plated onto Brucella blood agar (Anaerobe Systems, Morgan Hill, CA) for enumeration of total culturable anaerobic bacteria. Colonies were counted after 4 days of incubation at 39uC in a Bactron IV Anaerobic/Environmental Chamber (Sheldon Manufacturing, Cornelius, OR) under an N 2 :CO 2 :H 2 atmosphere of 90:5:5. Ammonia concentrations in gut contents were measured with a colorimetric procedure (6), and volatile fatty acid concentrations were measured by gas chromatography (18) .
A general analysis of variance was used to test for potential effects of treatment on dry matter intake, average daily gain, and gut concentrations of volatile fatty acids, ammonia, and logtransformed bacterial counts. The model statement included terms for treatment, replicate, pen, and pig, and a two-sided Dunnett multiple comparison procedure was used to compare treatment means with those of controls. All analyses were performed using STATISTIX9 Analytical Software (Tallahassee, FL). 21 ) did not differ (P . 0.05) between treatments. This result was expected because 1 week would likely be too short a time to adequately measure the effects of these compounds on daily gain. Accordingly, we concluded that the amounts of thymol and DIC administered in this study did not negatively affect feed intake. Jugl-Chizzola et al. (11) reported decreased feed intake by weaned pigs fed diets containing 1% (wt/wt) thyme (containing the equivalent 0.02% thymol) but not by pigs fed 0.1% thyme (the equivalent of 0.002% thymol). Trevisi et al. (23) reported a similar decreased feed intake. These investigators also did not find adverse effects on weight gain by weaned pigs fed diets containing 1% (wt/wt) thymol compared with pigs fed unsupplemented control diets.
RESULTS AND DISCUSSION
Campylobacter levels recovered from ileal and cecal contents of thymol-or DIC-treated pigs at necropsy did not differ from those recovered from pigs fed the unsupplemented control diet (Table 1) . Similarly, levels of total culturable anaerobes recovered from cecal contents were unaffected by 1| or 3| thymol (9.7 and 9.7 log CFU g 21 , respectively) or DIC treatment (9.8 and 9.7 log CFU g 21 , respectively) compared with controls (9.9 log CFU g 21 ) (SEM~0.10 log CFU g 21 ). Although the duration of the present study may have been too short to allow sufficient time for the treatments to exert their effects, it is more likely that the inhibitors were appreciably absorbed, degraded, or irreversibly bound to digesta within the proximal alimentary tract. Each treated pig ingested thymol at an average of 77 and 243 mg day 21 for the 1| and 3| treatments, respectively, and DIC at 1.6 and 5.1 mg day 21 for the 1| and 3| treatments, respectively. If 100% of each consumed dose had passed to the lower gut, then luminal concentrations would have been 0.8 and 2.5 mM thymol and 0.008 and 0.025 mM DIC, respectively (based on an estimated lower gut volume of 640 ml). These concentrations would exceed or be very close to concentrations previously determined to be efficacious in vitro (1). Rectal Campylobacter levels from thymol-treated pigs did not differ from those of controls. However, Campylobacter levels tended (P~0.07) to be lower in rectal contents collected from pigs fed diets supplemented with 1| or 3| DIC than in those from pigs fed the control diet, but it is unclear whether this difference can be directly attributed to luminal concentrations of DIC or to potential secondary effects of the inhibitor. Our finding that concentrations of ammonia and the volatile fatty acids acetate, propionate, and butyrate in ileal, cecal, and rectal contents were unaffected by thymol or DIC treatment (P . 0.05) again suggests that the amounts of these inhibitors reaching these gastrointestinal sites were not high enough to affect production of these fermentative end products (Table 2) .
Thymol and DIC have been investigated as feed additives that can be used to reduce the energetically wasteful process of ruminal protein degradation in cattle without producing adverse effects on animal health (2, 5). Varel and Miller (24) recognized the deaminase inhibiting potential of DIC for controlling gaseous emissions from livestock waste, and in vitro studies revealed that inhibition of amino acid metabolism by these chemicals may be a metabolic target for the control of foodborne Campylobacter (1) . Results from the present study indicated that neither thymol nor DIC negatively affected dry matter intake or live weight gain when fed for 7 days in diets supplemented with less than or equal to 0.0201% thymol or 0.00042% DIC (wt/wt). However, these treatments were not effective for reducing Campylobacter in the lower gut, most likely because these inhibitory compounds were absorbed or degraded in the stomach or small intestine. Although these compounds were effective for killing Campylobacter in vitro (1) , in the present in vivo study they did not appear to be effective for reducing Campylobacter in the swine intestinal tract. These results indicate that encapsulation or other protective technologies will likely be needed to deliver effective concentrations of these compounds to the lower gut to enhance their efficacy against Campylobacter in growing swine.
